Publications by authors named "Satoshi Uno"

Claim this Profile
P
Patient characteristics, treatment patterns, and survival outcomes in patients with castration-resistant prostate cancer: results from the J-CaP registry.
Mizuki Onozawa, Taketo Kawai, Shiro Hinotsu, Atsushi Saito, Takeshi Mitomi, Satoshi Uno

Jpn J Clin Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: 3-Year Postmarketing Surveillance Follow-Up in Japan.
Masataka Kuwana, Naoko Wakasugi, Tetsuji Hashida, Satoshi Uno, Takafumi Suda

J Rheumatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Firth-Type Penalized Methods of the Modified Poisson and Least-Squares Regression Analyses for Binary Outcomes.
Satoshi Uno, Hisashi Noma, Masahiko Gosho

Biom J· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bayesian Latent Class Models for Evaluating the Validity of Claim-based Definitions of Disease Outcomes.
Satoshi Uno, Toshiro Tango

Ann Clin Epidemiol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Safety and Effectiveness of Tacrolimus in Patients With Lupus Nephritis in Japan: 10-Year Analysis of the Real-World TRUST Study.
Tsutomu Takeuchi, Naoko Wakasugi, Tetsuji Hashida, Satoshi Uno, Hirofumi Makino

J Rheumatol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Third nationwide surveillance of bacterial pathogens in patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2020 and 2021: Antimicrobial susceptibility of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus saprophyticus.
Koichiro Wada, Ichiro Tsuboi, Satoshi Takahashi, Mitsuru Yasuda, Jun Miyazaki, Kazunobu Hikosaka, Satoshi Uno

J Infect Chemother· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The third nationwide surveillance of antimicrobial susceptibility against Neisseria gonorrhoeae from male urethritis in Japan, 2016-2017.
Mitsuru Yasuda, Satoshi Takahashi, Jun Miyazaki, Koichiro Wada, Kanao Kobayashi, Satoshi Uno

J Infect Chemother· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter, retrospective observational study investigating baseline characteristics and clinical outcomes in patients with hormone-sensitive prostate cancer treated with primary androgen deprivation therapy.
Satoru Taguchi, Mizuki Onozawa, Shiro Hinotsu, Taketo Kawai, Takeshi Mitomi, Satoshi Uno

Jpn J Clin Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tacrolimus use and renal function in pregnancy with lupus nephritis: Analysis of post-marketing surveillance data in Japan.
Kazuko Suzuki, Satoshi Uno, Naoko Wakasugi

Mod Rheumatol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study.
Hiroji Uemura, Kazuki Kobayashi, Akira Yokomizo, Shiro Hinotsu, Shigeo Horie, Satoshi Uno

Int J Clin Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: Interim Report of Postmarketing Surveillance in Japan.
Masataka Kuwana, Naoko Wakasugi, Toshinori Furuya, Satoshi Uno, Takafumi Suda

J Rheumatol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan: Comparison with the first surveillance report.
Satoshi Takahashi, Mitsuru Yasuda, Koichiro Wada, Masahiro Matsumoto, Hiroshi Hayami, Satoshi Uno

J Infect Chemother· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration-resistant prostate cancer: AFTERCAB study.
Hiroji Uemura, Kazuki Kobayashi, Akira Yokomizo, Shiro Hinotsu, Shigeo Horie, Satoshi Uno

BJUI Compass· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM.
Ichiro Nakamura, Hiroshi Maegawa, Kazuyuki Tobe, Satoshi Uno

Diabetes Ther· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evidence for long-term safety and effectiveness of ipragliflozin in treatment-naïve versus non-naïve Japanese patients with type 2 diabetes mellitus: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM).
Hiroshi Maegawa, Kazuyuki Tobe, Ichiro Nakamura, Satoshi Uno

Diabetol Int· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of ipragliflozin on liver function in Japanese type 2 diabetes mellitus patients: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM).
Kazuyuki Tobe, Hiroshi Maegawa, Ichiro Nakamura, Satoshi Uno

Endocr J· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nationwide surveillance of bacterial pathogens isolated from patients with acute uncomplicated cystitis in 2018: Conducted by the Japanese Research Group for Urinary Tract Infections (JRGU).
Koichiro Wada, Teruhiko Yokoyama, Satoshi Uno, Motoo Araki, Takuya Sadahira

J Infect Chemother· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Safety and Effectiveness of Ipragliflozin for Type 2 Diabetes in Japan: 12-Month Interim Results of the STELLA-LONG TERM Post-Marketing Surveillance Study.
Ichiro Nakamura, Hiroshi Maegawa, Kazuyuki Tobe, Satoshi Uno

Adv Ther· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Androgen-Depletion Therapy Prevails Not Only for Metastatic but Also for Nonmetastatic Hormone-Naïve Prostate Cancer in Japan-Recent Trends and Efficacy.
Mizuki Onozawa, Shiro Hinotsu, Atsushi Saito, Satoshi Uno, Hideyuki Akaza

Gan To Kagaku Ryoho· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM.
Ichiro Nakamura, Hiroshi Maegawa, Kazuyuki Tobe, Satoshi Uno

Diabetes Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM.
Ichiro Nakamura, Hiroshi Maegawa, Kazuyuki Tobe, Satoshi Uno

Diabetes Ther· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of ipragliflozin in Japanese patients with type 2 diabetes mellitus and impaired renal function: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM).
Kazuyuki Tobe, Hiroshi Maegawa, Ichiro Nakamura, Satoshi Uno

Diabetol Int· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Evidence for Long-Term Safety and Effectiveness of Ipragliflozin in Japanese Patients with Type 2 Diabetes Mellitus: final Results of a 3-Year Post-Marketing Surveillance Study (STELLA-LONG TERM).
Ichiro Nakamura, Hiroshi Maegawa, Kazuyuki Tobe, Satoshi Uno

Expert Opin Pharmacother· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular safety of mirabegron add-on therapy to tamsulosin for the treatment of overactive bladder in men with lower urinary tract symptoms: A post hoc analysis from the MATCH study.
Takao Katoh, Hidehiro Kakizaki, Kyu-Sung Lee, Kota Ishida, Daisuke Katou, Satoshi Uno

Low Urin Tract Symptoms· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mirabegron Add-On Therapy to Tamsulosin in Men with Overactive Bladder: Post Hoc Analyses of Efficacy from the MATCH Study.
Hidehiro Kakizaki, Kyu-Sung Lee, Daisuke Katou, Osamu Yamamoto, Budiwan Sumarsono, Satoshi Uno

Adv Ther· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis